Medical Supplies and Services News

Delivered ~20% U.S. procedure volume growth in the third quarter Third Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $55.7 million,...

1 October 2025 - 30 September 2026 Coloplast delivered 5% organic growth in Q4, driven by continued strength in Chronic Care and Interventional Urology. EBIT growth1 in constant currencies was 0% and...

1. oktober 2025 - 30. september 2026 Coloplast leverede 5% organisk vækst i 4. kvartal, drevet af fortsat stærk vækst i Chronic Care og Urologi. EBIT-væksten¹ i faste valutakurser var 0% og...

Announcement no. 10/2026Inside information Revised financial ambition towards 2030 includes 5-7% organic growth per year and an EBIT margin1 in constant currencies in the mid-20% range over the...

Selskabsmeddelelse nr. 10/2026Intern viden De reviderede finansielle ambitioner frem mod 2030 omfatter en organisk vækst på 5-7% om året og en EBIT-margin¹ i faste valutakurser i midten af 20'erne...

The audited report from one of the UK's largest and fastest growing Waqf funds, details £3.7 million invested in during 2025.

BETHLEHEM, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic tests and sample management solutions, announced today that it has...

بيت لحم، بنسلفانيا, Nov. 02, 2026 (GLOBE NEWSWIRE) --  أعلنتOraSure Technologies, Inc.، الشركة العالمية الرائدة في مجال اختبارات التشخيص في نقاط الرعاية الصحية والمنازل وحلول إدارة العينات، اليوم...

BETHLEHEM, Pennsylvanie, 02 nov. 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc., leader mondial des tests diagnostiques réalisables sur le lieu de soins ou à domicile et des solutions de...

DIJON, France CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutiqueinternationale spécialisée dans le développement d'auto-injecteurs sans aiguille pour les situationsd'urgence,...